Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca executives try to shift I-O focus with China, Brilinta wins
AstraZeneca executives try to shift I-O focus with China, Brilinta wins
AstraZeneca executives try to shift I-O focus with China, Brilinta wins
Submitted by
admin
on November 10, 2017 - 9:35am
Source:
Fierce Pharma
News Tags:
AstraZeneca
immuno-oncology
China
Brilinta
Headline:
AstraZeneca executives try to shift I-O focus with China, Brilinta wins
Do Not Allow Advertisers to Use My Personal information
